Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC) ...Middle East

DALLAS, Nov. 19, 2025 /PRNewswire/ -- Dialectic Therapeutics, Inc., a clinical-stage biotechnology company developing innovative anti-cancer drugs, today announced that patient dosing is underway in a clinical trial led by the renowned Drs. Elizabeth Stover, Joyce Liu, and Ursula...

Hence then, the article about dialectic therapeutics announces dosing of first patient in platinum resistant ovarian cancer proc was published today ( Wednesday 19/11/2025 - 07:10 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC) )

Also on site :

• Gaza plan phase two: US to discuss Hamas disarmament, Israeli withdrawal
• ‘I hope they show humanity’: Greenlanders fear Trump’s desire for minerals
• Amazon Has 'Super Warm' and ‘Soft' Mini Sheepskin Boots on Sale for $50, and They're 'Worth Every Penny'